NOTE - Quantum Genomics - Acheter, Obj. 13.0€
Quantum Genomics développe une nouvelle classe thérapeutique dans le traitement de l'hypertension et de l'insuffisance cardiaque. Firibastat est le premier antihypertenseur de sa catégorie. Son mécanisme d'action repose sur l'inhibition d'une enzyme cérébrale responsable du contrôle de la pression sanguine. Nous attendons un news flow de qualité pour 2022, ce qui nous amène à réitérer notre recommandation Acheter (1).Quantum Gernomics is a biotechnology firm specializing in the development of innovative drugs to combat cardiovascular diseases. Run by professionals in creating and managing technological start-ups and drug development, as well as researchers and inventors, Co. has established contractual relations with institutions of academic excellence in France (Inserm, CollA
Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.